Fosun International LTD Kal Vista Pharmaceuticals, Inc. Transaction History

Fosun International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$18.44 - $30.89 $1.34 Million - $2.24 Million	-72,606 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$16.51 - $31.1 $1.07 Million - $2.02 Million	-64,837 Reduced 47.17%	72,606 $2.03 Million
Q4 2018 Jan 31, 2019	BUY	$16.21 - $24.06 $2.23 Million - $3.31 Million	137,443 New	137,443 $2.44 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.